Renin-angiotensin-aldosterone system inhibitor dosing after initiation of outpatient sodium zirconium cyclosilicate therapy: The GALVANIZE RAASi real-world evidence study
media
posted on 2025-06-16, 10:06 authored by Adis journals on behalf of, Abiy Agiro, Alexandra Greatsinger, Fan Mu, Erin E. Cook, Jingyi Chen, Manasvi Sundar, Angela Zhao, Ellen Colman, Arun MalhotraArticle full text
The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
